Nucaps

For the first time, Nucaps is leading a strategic R&D project: NUTRACAPS. This ambitious project, developed by a consortium formed by Nucaps (leader), Iberfruta, Isanatur, Ingredalia, Ojer Pharma, Espiga I+D, UNAV, CNTA, and NAGRIFOOD, proposes innovative solutions based on nanoencapsulated bioactive compounds to address Metabolic Syndrome and improve wound healing.

NUTRACAPS combines functional and nutraceutical ingredients of natural origin, such as omega-6 fatty acids and quercetin, recognized for their anti-inflammatory properties, their ability to reduce insulin resistance, and their skin-repairing effects. Through nanoencapsulation, the efficacy and bioavailability of these compounds are optimized, enabling their application in oral products (nutraceuticals) and topical treatments.

The project stands out for its commitment to the circular economy, reusing agro-food by-products from Navarra and exploring new natural sources, such as blackcurrant, which uniquely combines omega-6 fatty acids and quercetin. This sustainable approach reinforces the efficient use of resources and positions Navarra as a hub for innovation in health and food technology.

NUTRACAPS includes advanced in vitro and in vivo studies, as well as analyses of stability, safety, and economic feasibility to ensure the applicability of these solutions in food and nutra/dermaceutical matrices. The project is co-financed by the Government of Navarra and the European Regional Development Fund (ERDF), consolidating the region’s leadership in R&D&i.

With NUTRACAPS, Nucaps and its partners are betting on a future where health, sustainability, and technology converge to improve quality of life, demonstrating Navarra’s potential as a reference in innovation.